Meet New Members.

alt

www.biodesix.com

Biodesix is advancing personalized patient care by providing clinicians with accurate and important information relating to a patient’s diagnosis, prognosis, or response to a specific therapy. Biodesix works with research scientists, clinicians, and biotech and pharmaceutical companies to discover clinically valuable tests based on a patient’s unique molecular phenotype.

Official Representative: David Brunel, Chief Executive Officer and Director

 

alt

www.bioscale.com

BioScale develops, manufactures and promotes a sophisticated protein measurement technology to accelerate drug discovery, development and production of biological and pharmaceutical products. The simplicity, power and speed of BioScale’s innovative technology enables their customers to achieve major advancements in protein research that were not previously attainable by allowing the ultra-sensitive detection of proteins in multiple types of complex biological samples.

Official Representative: Mark Lundstrom, Chief Executive Officer and Founder

 

alt

www.corning.com

Corning Life Sciences brings new and innovative laboratory technologies to researchers worldwide and helps customers succeed by providing innovative, high-quality products and services in the areas of polymer science, biochemistry and molecular biology, glass melting and forming, surface modification, and characterization science.

Official Representative: Ron Verkleeren, Division Vice President

 

alt

www.DVSsciences.com

DVS Sciences Inc. is an analytical equipment and reagents development company that produces and markets the
CyTOF®, a high throughput mass cytometer for individual cell analysis based on a novel elemental mass-spectrometry detection technology, and the MAXPAR® system of reagents related to massively multi-parametric assays. DVS is committed to developing robust, innovative instrumentation, reagents and consumables that accelerate medical research and transform drug discovery via highly multiplexed bio-analysis.

Official Representative: Scott Tanner, President & CEO

 

Fluxion Biosciences

www.fluxionbio.com

Fluxion's goal is to create innovative solutions for its customers which offer superior performance, simplified workflows and cost savings over conventional assay techniques. Their products include research and diagnostic platforms that automate complex cellular assays.

Official Representative: Heff Jensen, CEO

 

alt

www.fluidigm.com

Fluidigm develops, manufactures and markets microfluidic systems for growth markets in the life science and agricultural biotechnology, or Ag-Bio, industries. Fluidigm’s proprietary microfluidic systems consist of instruments and consumables, including integrated fluidic circuits, or chips, and reagents. These systems are designed to significantly simplify experimental workflow, increase throughput and reduce costs, while providing the excellent data quality demanded by customers. Fluidigm actively markets three microfluidic systems including nine different commercial chips to leading pharmaceutical and biotechnology companies, academic institutions and Ag-Bio companies.

Official Representative: Gajus Worthington, President, CEO and Co-Founder

 

alt

www.hansonresearch.com

Located in Chatsworth, California, Hanson Research Corporation is a leader in dissolution test technology for the pharmaceutical industry. Hanson offers a complete line of tablet dissolution, topical and transdermal test systems.

Official Representative: Royal Hanson, Chairman & CEO

 

alt

www.intellicyt.com

IntelliCyt Corporation is located in Albuquerque, New Mexico. The company develops and markets innovative high throughput cell screening solutions using flow cytometry technology for drug discovery and life science research. IntelliCyt offers innovative products, cell-screening expertise, technological advances and services that make it possible for researchers to handle large-scale cell-based assays faster than previously possible.

Official Representative: Terry Dunlay, CEO

 

alt

www.KPL.com

KPL, Inc. develops, manufactures and market high quality immunochemicals for life science and in vitro diagnostics. KPL was the first company to commercialize affinity purified secondary antibodies, a valuable tool for biological research and in vitro diagnostic testing. Since then KPL has introduced over 700 reagents and complete assay kits for protein visualization and nucleic acid detection that address the needs of cell biology, immunology, protein chemistry and molecular biology scientists.

Official Representative: Albert Perry, President

 

Pace Analytical Services—LabOps Division

www.pacelabs.com

Located in Minneapolis, Minnesota, Pace Analytical provides analytical and environmental testing services, field sampling services, and on-site laboratory operations and management services for a variety of projects. Pace’s Lab Ops Division provides in-depth experience with on-site operation of laboratories. The Instrument Support Group provides equipment services including qualifications/calibrations, preventative maintenance, repairs, installations and laboratory relocations.

Official Representative: Gabe Le Brun, Vice President & COO

 

alt

www.sensorin.com

Sensorin is developing and commercializing a novel, proprietary and versatile sensing technology platform. The company is initially focusing on pH measurement in high-value manufacturing, where an internally referenced, continuously self-calibrating sensor without drift is advantageous. The Sensorin system uses solid state molecular electronics and is reliable, accurate and robust for deployment in process applications. The company's first product will be a pH sensing system for biologics manufacturing.

Official Representative: Carolyn R. Kahn, CEO

 

alt

www.STRATEC.com

STRATEC Biomedical AG is located in Birkenfeld, Germany. The company develops and manufactures fully automated analyzer systems based on its own patented technologies for its partners in the fields of clinical diagnostics and biotechnology. STRATEC’s partners are mostly global players operating in the in-vitro diagnostics industry. These companies market STRATEC’s systems, in general together with their own reagents, as system solutions to laboratories, blood banks, and research institutes around the world.

Official Representative: Bernd M. Steidle, Member of the Board of Management

"As the CEO of two companies that have each been ALSSA members during the past 12 years, I have consistently made attendance of the Spring and Fall ALSSA meetings a priority. There is no other setting in our industry that comes close to offering the combination of relevant market topics, top notch industry speakers and the opportunity to network with fellow CEOs with the efficiency of an ALSSA weekend. I always return with new information to share with my executive team."

Joe Keegan
President & CEO
ForteBio